INS and type 2 diabetes mellitus: In APP23-ob/ob mice, a model of CAA and T2DM, metformin (350 mg/kg daily) administered for about 14 months reduced the number of cerebral blood vessels with amyloid β deposits, increasing the insulin-degrading enzyme (insulysin) [136].